diabetes

February 20, 2020

Post-transplant diabetes may be reversible: study

Post-transplantation diabetes mellitus (PTDM), a common complication of immunosuppressive drugs that are given to prevent transplant rejection, may be reversible and at least partially preventable, researchers at VUMC report.

By Bill Snyder
January 16, 2020

Pediatric diabetes, palliative care focus of new Friends of Children’s Hospital gift

Friends of Monroe Carell Jr. Children’s Hospital at Vanderbilt, a volunteer organization, recently committed $1 million over the next three years to be split between two crucial pediatric programs: diabetes and palliative care.

By Nancy Humphrey
December 18, 2019

Telehealth grant boosts diabetes prevention efforts

Vanderbilt’s Diabetes Prevention Program (DPP) has demonstrated its effectiveness at helping employees lose weight as a means of preventing Type 2 diabetes and has received a five-year grant from the National Institutes of Health (NIH) to expand the program using telehealth.

By Wayne Wood
Patrick Hu, MD, PhD, has been named assistant dean for Physician-Researcher Training and director of the Office for Medical Student Research.
December 4, 2019

Genetic screen in worms reveals critical step in insulin synthesis

The identification of a protein important for insulin synthesis may hold clues for understanding the pathogenesis of diabetes.

By Leigh MacMillan
November 7, 2019

Griffith honored for her contributions to telehealth initiatives

Michelle Griffith, MD, recently received an award for her work building networks for and advocacy of telehealth.

By Jill Clendening
October 31, 2019

Vanderbilt investigators lead effort to create map of the human kidney

Short of mandating universal diabetes treatment, regular exercise and low-calorie diets, little can be done to stem the rising tide of kidney failure — unless scientists can figure out why exactly the kidney’s filtration units, the glomeruli, stop working.

By Bill Snyder
October 3, 2019

Diabetes drug study explores cardiovascular risks for patients with kidney disease

An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease.
By Paul Govern
August 22, 2019

Discovery may point to better treatments for Type 1 diabetes

Researchers have made a paradigm-shifting discovery that could lead to new treatments, better health and longer life for patients with Type 1 diabetes.
By Bill Snyder
July 29, 2019

New role for microtubules in diabetes

Microtubules — part of the cell's cytoskeleton — regulate the secretion of insulin, suggesting that they may be a new target for treating diabetes.
By Bill Snyder
June 9, 2019

Study drug delays type 1 diabetes in high risk children and adults

Drug delays onset of type 1 diabetes by two years
By Craig Boerner
April 25, 2019

Study expands insight on shrinking pancreas in type 1 diabetes

Researchers with the Vanderbilt Diabetes Research and Training Center (DRTC) have discovered a progressive decline in pancreas volume over a one-year period in children and adolescents with newly diagnosed Type 1 diabetes.
By Jill Clendening
April 22, 2019

Asia’s diabetes epidemic preferentially kills women, the middle-aged: study

Diabetes has reached epidemic proportions in Asia and has dramatically increased the risk of premature death, especially among women and middle-aged people, a multinational study led by Vanderbilt University researchers has found.
By Bill Snyder
January 17, 2019

Building a pancreas

Vanderbilt investigators are defining the genetic programs that control the development of pancreatic beta cells — studies that could inform new cellular or regenerative therapies for diabetes.
By Leigh MacMillan
1 … 5 6 7 8 9 … 18